Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis

Revolutionary bead-based technology enables reliable biomarker detection in challenging samples, transforming clinical diagnostic performance and research workflows.

Previous
Previous

42nd Annual J.P. Morgan Healthcare Conference

Next
Next

Saliva Diagnostics Webinar: Early Detection of Disease